Greenberg PE[au] - Search Results

Year	Number of Results
1993	2
1995	2
1996	1
1997	1
1998	1
1999	4
2000	1
2001	6
2002	3
2003	5
2004	1
2005	2
2006	1
2007	2
2008	3
2009	6
2010	5
2011	1
2012	1
2013	1
2014	1
2015	1
2018	1
2019	2
2020	1
2021	3
2022	1
2023	0

1

The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018).

Greenberg PE, Fournier AA, Sisitsky T, Simes M, Berman R, Koenigsberg SH, Kessler RC. Greenberg PE, et al. Pharmacoeconomics. 2021 Jun;39(6):653-665. doi: 10.1007/s40273-021-01019-4. Epub 2021 May 5. Pharmacoeconomics. 2021. PMID: 33950419 Free PMC article.

2

The economic burden of adults with major depressive disorder in the United States (2005 and 2010).

Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. Greenberg PE, et al. J Clin Psychiatry. 2015 Feb;76(2):155-62. doi: 10.4088/JCP.14m09298. J Clin Psychiatry. 2015. PMID: 25742202 Free article.

3

Introduction to the Special Issue of PharmacoEconomics on Major Depressive Disorders.

Greenberg PE, Sisitsky T. Greenberg PE, et al. Pharmacoeconomics. 2021 Jun;39(6):617. doi: 10.1007/s40273-021-01041-6. Epub 2021 May 13. Pharmacoeconomics. 2021. PMID: 33982197 Free PMC article. No abstract available.

4

Cost of illness: an ongoing battle worth fighting.

Greenberg PE. Greenberg PE. Pharmacoeconomics. 2014 Dec;32(12):1151-2. doi: 10.1007/s40273-014-0217-z. Pharmacoeconomics. 2014. PMID: 25204852 No abstract available.

5

Does generic substitution always make sense?

Greenberg PE. Greenberg PE. J Med Econ. 2008;11(3):547-53. doi: 10.3111/13696990802371075. J Med Econ. 2008. PMID: 19450104 No abstract available.

6

Assessing the economic impact of psychiatric disorders: where to begin?

Greenberg PE, Leong SA, Birnbaum HG. Greenberg PE, et al. Expert Opin Pharmacother. 2001 Apr;2(4):641-52. doi: 10.1517/14656566.2.4.641. Expert Opin Pharmacother. 2001. PMID: 11336613 Review.

7

The economic burden of depression in the US: societal and patient perspectives.

Greenberg PE, Birnbaum HG. Greenberg PE, et al. Expert Opin Pharmacother. 2005 Mar;6(3):369-76. doi: 10.1517/14656566.6.3.369. Expert Opin Pharmacother. 2005. PMID: 15794728 Review.

8

The economic burden of depression with painful symptoms.

Greenberg PE, Leong SA, Birnbaum HG, Robinson RL. Greenberg PE, et al. J Clin Psychiatry. 2003;64 Suppl 7:17-23. J Clin Psychiatry. 2003. PMID: 12755648 Review.

9

The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.

Duh MS, Cahill KE, Paradis PE, Cremieux PY, Greenberg PE. Duh MS, et al. Among authors: greenberg pe. Expert Opin Pharmacother. 2009 Oct;10(14):2317-28. doi: 10.1517/14656560903140525. Expert Opin Pharmacother. 2009. PMID: 19663636 Review.

10

Medicaid spending burden among beneficiaries with treatment-resistant depression.

Pilon D, Sheehan JJ, Szukis H, Singer D, Jacques P, Lejeune D, Lefebvre P, Greenberg PE. Pilon D, et al. Among authors: greenberg pe. J Comp Eff Res. 2019 Apr;8(6):381-392. doi: 10.2217/cer-2018-0140. Epub 2019 Feb 8. J Comp Eff Res. 2019. PMID: 30734581 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results